Key Findings
The Asia-Pacific non-PVC IV bags market is set to register a CAGR of 8.30% during the forecast period, 2021-2028. The growing demand for technologically advanced healthcare solutions with cost-effective benefits offers lucrative growth opportunities.

Market Insights
Singapore, Japan, Indonesia, Australia & New Zealand, Malaysia, China, South Korea, India, and Rest of Asia-Pacific are evaluated for the Asia-Pacific non-PVC IV bags market growth assessment. In South Korea, the ban on PVC use is estimated to boost the adoption of PVC alternatives like the non-PVC IV bags. In addition, colored PET bottles, PVC material, and PET bottles that use adhesives were barred from use during manufacturing, for reducing plastic waste. At the same time, given the lack of substitutes, PVC is allowed for use in functional foods and medicines. Further, the elderly population accounted for almost 16.5% of the total population in 2021. Such factors are expected to increase the adoption of non-PVC bags.
According to the India Brand Equity Foundation, India is among the top 20 markets for medical devices globally. The medical devices market is projected to reach US$ 65 billion by 2024. The market entails large multinationals and small & mid-sized companies. Also, the government initiatives to enhance the medical devices sector, emphasis on the research & development, and 100% FDI for medical devices make India a conducive market for non-PVC IV bags development. Moreover, the Ministry of Environment and Forests banned the use of chlorinated plastics, which benefits the market prospects.

Competitive Insights
Some of the prominent companies in the market include Otsuka, MEDIPHARMAPLAN, JW Life Science, Huaren Pharmaceutical, Kraton Corporation, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments